Top Markets
#1 Black Phoenix Black Phoenix +829.59%
#2 pipedog pipedog +41.28%
#3 PondCoin PondCoin +35.42%
#4 Bless Bless +35.40%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.74%
#6 SAFEcoin SAFEcoin +26.00%
#7 Beam Beam +24.62%
#8 Seeker Seeker +21.01%
#9 Magma Finance Magma Finance +20.64%
#10 YFSX YFSX +16.15%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rang in Aktien #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Aktienkurs
$64.97
Zuletzt synchronisiert: 2024-05-20
Marktkapitalisierung
$1.97B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Alpine Immune Sciences, Inc. (ALPN)

Kategorie

Healthcare
Operative Marge für Alpine Immune Sciences, Inc. (ALPN)
Operative Marge zum August 2026 TTM: -75.16%
Laut den neuesten Finanzberichten und dem Aktienkurs von Alpine Immune Sciences, Inc. beträgt die aktuelle operative Marge (TTM) -75.16%. Am Ende des Jahres 2022 lag die operative Marge bei -193.41%.
Historie der operativen Marge von Alpine Immune Sciences, Inc. von 2012 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) -75.16% 0.00%
2023 -75.16% -61.14%
2022 -193.41% -9.06%
2021 -212.68% -30.94%
2020 -307.97% -87.70%
2019 -2,504.25% -53.33%
2018 -5,365.96% 520.31%
2017 -865.05% -20.01%
2016 -1,081.42% -76.76%
2015 -4,654.07% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -100.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.38%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -100.34%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -98.02%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.